Results 121 to 130 of about 22,846 (183)

Contemporary management of treatment-related dermatologic toxicities in gynecologic cancers: a systematic review based on evidence from 2021 to 2025. [PDF]

Front Med (Lausanne)
Wang S, Hou R, Wang R, Liu C, Xu S.
europepmc   +1 more source

Multifunctional Bismuth Nanoplatforms Augment Radioactive Iodine Therapy in Anaplastic Thyroid Cancer. [PDF]

Int J Nanomedicine
Qu X, Liu T, Wang Y, Wei X, Yang Y, Gu L, Yang K, Zhang J, Liu Y, Liang Y, Zheng Y, Yang A.   +11 more
europepmc   +1 more source

Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapy. [PDF]

Cell Death Dis
Gorainow N, Sander F, Picard D, Frölich MC, Eul K, Etemadi Afshar S, Asche J, Monje M, Raabe E, Bartl J, Borkhardt A, Reifenberger G, Dünker N, Busch M, Pauck D, Qin N, Matschke J, Remke M, Jendrossek V.   +18 more
europepmc   +1 more source

Old Drugs, New Battles: Unleashing Repurposed Drug Classes in Triple-Negative Breast Cancer Treatment. [PDF]

Int J Mol Sci
Tshimweneka VS, Mhlanga TV.
europepmc   +1 more source

Drug resistance in glioblastoma: Challenges, mechanisms and therapeutic strategies (Review). [PDF]

Mol Clin Oncol
Durga YK, Pusapati RV.
europepmc   +1 more source

Novel antagonist APG-115 targets MDM2-p53 to induce p53-mediated apoptosis and radiosensitization in colorectal cancer. [PDF]

Clin Exp Med
Yi H, Han Y, Wang X, Li Q, Xiong L, Li S.   +5 more
europepmc   +1 more source

Early and Late Effects of Difluorodeoxycytidine on Murine Cell Radiosensitivity <i>In Vivo</i>. [PDF]

In Vivo
Cruz-Vallejo V, Vallarino-Kelly T, López-Pavón S, Quezada-Vidal J, Morales-Ramírez P.   +4 more
europepmc   +1 more source